Management will conduct a live presentation and question-and-answer session beginning at 4:30 PM ET. Interested participants are encouraged to dial in ten minutes before the start of the webcast. An archived recording of the proceedings will be made available through the Investor Relations section of the company's website shortly after the event concludes.
In section Releases
CytoSorbents Sets Date for Second Quarter 2026 Financial Results
Princeton-based medical technology firm CytoSorbents Corporation will host a conference call on August 6, 2026, to disclose its financial results for the second quarter. The company, which specializes in blood purification systems for intensive care and cardiac surgery, will also present recent business highlights following the market close.
CytoSorbents continues to focus on its proprietary polymer bead technology, designed to remove toxic substances from blood during critical care procedures. While its flagship product, CytoSorb, is widely used across Europe and international markets, the company remains in the development phase for its DrugSorb-ATR system within the United States and Canada. Investors will be looking for updates on the firm’s regulatory progress and its broader strategy to reach operating cash-flow break-even during the latter half of 2026.
Comments (0)
No comments yet. Be the first!